| 38.52 | -0.30 / -0.77% |
Data as of 4:00pm ET | Day’s Change |
| 38.51 | -0.0077 / -0.02% |
Volume: 10.2K |
| Endo Health Solutions Inc (ENDP): Today's Featured Health Care Laggard 9:44am / TheStreet.com | Crucial Junctures May Offer Opportunity to These Companies Jun 13 / MotleyFool.com |
| Endo Health Reaches New 52-Week High (ENDP) Jun 14 / TheStreet.com | Endo to Trim Workforce - Analyst Blog Jun 06 / Zacks.com |
| Short Interest In Endo Health Solutions Moves 13.8% Higher Jun 13 / TheStreet.com |
| Previous close | 38.82 |
| Today’s open | 38.74 |
| Day’s range | 38.52 - 39.20 |
| Volume | 1,094,800 |
| Average volume (3 months) | 2,354,840 |
| Market cap | $4.4B |
| Dividend yield | -- |
| Earnings growth (last year) | -512.90% |
| Earnings growth (this year) | -13.79% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +10.89% |
| P/E ratio | NM |
| Price/Sales | 1.00 |
| Price/Book | 4.01 |
| Today’s change | Today’s % change | |
|---|---|---|
| SLXPSalix Pharmaceutical... | -0.41 | -0.61% |
| JAZZJazz Pharmaceuticals... | -1.38 | -1.98% |
| ALKSAlkermes Plc | -1.00 | -3.34% |
| SGENSeattle Genetics Inc | -0.71 | -2.20% |
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | $1.15 |
| Annual revenue (last year) | $3.0B |
| Annual profit (last year) | -$740.3M |
| Net profit margin | -24.45% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Rajiv de Silva, MBA |
Chief Financial Officer & Executive Vice President Alan G. Levin, CPA |
Corporate headquarters Malvern, Pennsylvania |
